118 related articles for article (PubMed ID: 12358784)
1. N-Methyl-D-aspartate receptor subtype-selectivity of homoquinolinate: an electrophysiological and radioligand binding study using both native and recombinant receptors.
Grimwood S; Wafford KA; Macaulay A; Hutson PH
J Neurochem; 2002 Aug; 82(4):794-800. PubMed ID: 12358784
[TBL] [Abstract][Full Text] [Related]
2. [3H]homoquinolinate binds to a subpopulation of NMDA receptors and to a novel binding site.
Brown JC; Tse HW; Skifter DA; Christie JM; Andaloro VJ; Kemp MC; Watkins JC; Jane DE; Monaghan DT
J Neurochem; 1998 Oct; 71(4):1464-70. PubMed ID: 9751179
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological heterogeneity of NMDA receptors: characterization of NR1a/NR2D heteromers expressed in Xenopus oocytes.
Buller AL; Monaghan DT
Eur J Pharmacol; 1997 Feb; 320(1):87-94. PubMed ID: 9049607
[TBL] [Abstract][Full Text] [Related]
4. The molecular basis of NMDA receptor subtypes: native receptor diversity is predicted by subunit composition.
Buller AL; Larson HC; Schneider BE; Beaton JA; Morrisett RA; Monaghan DT
J Neurosci; 1994 Sep; 14(9):5471-84. PubMed ID: 7916045
[TBL] [Abstract][Full Text] [Related]
5. Molecular and pharmacological characterization of recombinant rat/mice N-methyl-D-aspartate receptor subtypes in the yeast Saccharomyces cerevisiae.
Becker J; Li Z; Noe CR
Eur J Biochem; 1998 Sep; 256(2):427-35. PubMed ID: 9760184
[TBL] [Abstract][Full Text] [Related]
6. Characterisation of N-methyl-D-aspartate receptor-specific [(3)H]Ifenprodil binding to recombinant human NR1a/NR2B receptors compared with native receptors in rodent brain membranes.
Grimwood S; Richards P; Murray F; Harrison N; Wingrove PB; Hutson PH
J Neurochem; 2000 Dec; 75(6):2455-63. PubMed ID: 11080197
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological properties of recombinant human N-methyl-D-aspartate receptors comprising NR1a/NR2A and NR1a/NR2B subunit assemblies expressed in permanently transfected mouse fibroblast cells.
Priestley T; Laughton P; Myers J; Le Bourdellés B; Kerby J; Whiting PJ
Mol Pharmacol; 1995 Nov; 48(5):841-8. PubMed ID: 7476914
[TBL] [Abstract][Full Text] [Related]
8. Effects of memantine on recombinant rat NMDA receptors expressed in HEK 293 cells.
Bresink I; Benke TA; Collett VJ; Seal AJ; Parsons CG; Henley JM; Collingridge GL
Br J Pharmacol; 1996 Sep; 119(2):195-204. PubMed ID: 8886398
[TBL] [Abstract][Full Text] [Related]
9. Functional expression of recombinant N-methyl-D-aspartate receptors in the yeast Saccharomyces cerevisiae--localization and pharmacological characterization.
Li Z; Becker J; Noe CR
Eur J Biochem; 1998 Mar; 252(3):391-9. PubMed ID: 9546654
[TBL] [Abstract][Full Text] [Related]
10. Ligand affinities at recombinant N-methyl-D-aspartate receptors depend on subunit composition.
Laurie DJ; Seeburg PH
Eur J Pharmacol; 1994 Aug; 268(3):335-45. PubMed ID: 7528680
[TBL] [Abstract][Full Text] [Related]
11. Generation and characterisation of stable cell lines expressing recombinant human N-methyl-D-aspartate receptor subtypes.
Grimwood S; Le Bourdellès B; Atack JR; Barton C; Cockett W; Cook SM; Gilbert E; Hutson PH; McKernan RM; Myers J; Ragan CI; Wingrove PB; Whiting PJ
J Neurochem; 1996 Jun; 66(6):2239-47. PubMed ID: 8632144
[TBL] [Abstract][Full Text] [Related]
12. Characterization of glutamate binding sites in receptors assembled from transfected NMDA receptor subunits.
Kendrick SJ; Lynch DR; Pritchett DB
J Neurochem; 1996 Aug; 67(2):608-16. PubMed ID: 8764586
[TBL] [Abstract][Full Text] [Related]
13. Characterization of haloperidol and trifluperidol as subtype-selective N-methyl-D-aspartate (NMDA) receptor antagonists using [3H]TCP and [3H]ifenprodil binding in rat brain membranes.
Coughenour LL; Cordon JJ
J Pharmacol Exp Ther; 1997 Feb; 280(2):584-92. PubMed ID: 9023267
[TBL] [Abstract][Full Text] [Related]
14. Influence of a threonine residue in the S2 ligand binding domain in determining agonist potency and deactivation rate of recombinant NR1a/NR2D NMDA receptors.
Chen PE; Johnston AR; Mok MH; Schoepfer R; Wyllie DJ
J Physiol; 2004 Jul; 558(Pt 1):45-58. PubMed ID: 15107472
[TBL] [Abstract][Full Text] [Related]
15. Modulation of 45Ca2+ influx into cells stably expressing recombinant human NMDA receptors by ligands acting at distinct recognition sites.
Grimwood S; Gilbert E; Ragan CI; Hutson PH
J Neurochem; 1996 Jun; 66(6):2589-95. PubMed ID: 8632186
[TBL] [Abstract][Full Text] [Related]
16. Ifenprodil discriminates subtypes of the N-methyl-D-aspartate receptor: selectivity and mechanisms at recombinant heteromeric receptors.
Williams K
Mol Pharmacol; 1993 Oct; 44(4):851-9. PubMed ID: 7901753
[TBL] [Abstract][Full Text] [Related]
17. The endogenous agonist quinolinic acid and the non endogenous homoquinolinic acid discriminate between NMDAR2 receptor subunits.
de Carvalho LP; Bochet P; Rossier J
Neurochem Int; 1996 Apr; 28(4):445-52. PubMed ID: 8740453
[TBL] [Abstract][Full Text] [Related]
18. In vitro characterization of novel NR2B selective NMDA receptor antagonists.
Kiss L; Cheng G; Bednar B; Bednar RA; Bennett PB; Kane SA; McIntyre CJ; McCauley JA; Koblan KS
Neurochem Int; 2005 May; 46(6):453-64. PubMed ID: 15769547
[TBL] [Abstract][Full Text] [Related]
19. Inducible expression and pharmacological characterization of recombinant rat NR1a/NR2A NMDA receptors.
Kurkó D; Dezso P; Boros A; Kolok S; Fodor L; Nagy J; Szombathelyi Z
Neurochem Int; 2005 Apr; 46(5):369-79. PubMed ID: 15737435
[TBL] [Abstract][Full Text] [Related]
20. Native N-methyl-D-aspartate receptors containing NR2A and NR2B subunits have pharmacologically distinct competitive antagonist binding sites.
Christie JM; Jane DE; Monaghan DT
J Pharmacol Exp Ther; 2000 Mar; 292(3):1169-74. PubMed ID: 10688637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
